Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL NANOCAGE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/012952
Kind Code:
A1
Abstract:
The present invention relates to a novel recombinant nanocage and use thereof and to an anticancer agent comprising as an effective ingredient a complex nanocage including a nanocage and an immunogenic apoptosis inducer loaded inside the nanocage, the nanocage being formed by self-assembly of a fusion protein including a phagocytosis-promoting protein and a self-assembling protein.

Inventors:
NAM GI HOON (KR)
LEE EUN JUNG (KR)
YANG YOO SOO (KR)
JEONG CHERL HYUN (KR)
KIM IN-SAN (KR)
KIM KWANGMEYUNG (KR)
Application Number:
PCT/KR2017/007679
Publication Date:
January 18, 2018
Filing Date:
July 17, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOREA INST SCI & TECH (KR)
International Classes:
A61K31/69; A61K9/51; A61K31/704; A61K39/395; C07K14/47; C07K14/79
Domestic Patent References:
WO2016061231A12016-04-21
Foreign References:
KR20130039672A2013-04-22
US20150329616A12015-11-19
KR20150085721A2015-07-24
Other References:
LIANG, MINMIN ET AL.: "H-ferritm-nanocaged Doxorubicin Nanoparticles Specifically Target and Kill Tumors with a Single-dose Injection", PNAS, vol. 111, no. 41, 2014, pages 14900 - 14905, XP055202963, DOI: doi:10.1073/pnas.1407808111
See also references of EP 3501509A4
Attorney, Agent or Firm:
HAN, Yun Ho (KR)
Download PDF: